Olaplex Holdings, Inc. (OLPX) Covered Calls

Olaplex Holdings is a science-led beauty company focused on hair health through its proprietary bond-building technology. The firm develops and sells a suite of hair care products that repair, strengthen, and protect hair on a molecular level. Serving professional salons, prestige retailers, and direct consumers, Olaplex utilizes its patent-protected Bis-amino technology to maintain its position as a category leader in the high-growth prestige hair care market.

You can sell covered calls on Olaplex Holdings, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for OLPX (prices last updated Tue 4:16 PM ET):

Olaplex Holdings, Inc. (OLPX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.65 +0.05 1.46 1.69 997K - 1.1
Covered Calls For Olaplex Holdings, Inc. (OLPX)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Mar 20 1.5 0.00 1.69 -11.2% -163.5%
Apr 17 1.5 0.00 1.69 -11.2% -77.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Olaplex Holdings (OLPX) operates as a high-growth, science-enabled beauty platform that revolutionized the hair care industry with its patented bond-building technology. The company’s products are centered on a single active ingredient, Bis-Aminopropyl Diglycol Dimaleate, which works at the molecular level to repair disulfide bonds in hair damaged by chemical treatments or heat. Olaplex utilizes an omni-channel distribution strategy that spans Professional, Specialty Retail (such as Sephora and Ulta), and Direct-to-Consumer (DTC) channels, ensuring a presence at every touchpoint of the premium hair care journey.

The company’s growth engine is increasingly fueled by its "Pro-First" heritage, where professional stylists act as brand ambassadors and primary educators for the consumer base. Following the 2025 acquisition of the biotech firm Purvala, Olaplex has integrated advanced delivery systems into its 2026 product pipeline to enhance the efficacy of its topical treatments. Despite recent headwinds in specialty retail, the firm has maintained a robust gross margin profile, supported by its asset-light manufacturing model and a vast intellectual property portfolio containing over 170 patents worldwide.

Competitive Landscape

The prestige hair care market is intensely competitive, with a shift toward clinical and results-driven formulations. Olaplex competes for shelf space and stylist mindshare with The Estée Lauder Companies Inc. (Aveda and Bumble and bumble) and Coty Inc. (Wella and Nioxin). In the digital-native and high-growth retail space, it faces rivalry from Oddity Tech Ltd. and e.l.f. Beauty, Inc..

Olaplex differentiates itself through its "clean beauty" positioning and the scientifically verifiable results of its bond-building formulas. Unlike traditional cosmetic hair products that provide superficial coating, the company’s focus on internal hair structure provides a distinct clinical moat. This technical advantage allows the firm to command premium pricing and maintain high brand loyalty among professional colorists, who view the product as an essential "insurance policy" during high-stress chemical services. Its ability to scale quickly into adjacent categories—such as the recent launch of its Lashbond Building Serum—further showcases the versatility of its core technology.

Strategic Outlook and Innovation

Strategic priorities for 2026 are defined by the "Stabilize and Scale" initiative, aimed at reversing the sales declines seen in late 2024. Management has signaled a significant increase in commercial investment for the first half of 2026, focusing on "Digital Storytelling" and revamped DTC capabilities to lower customer acquisition costs. With the Q4 2025 earnings report showing a stabilization in international markets and a reaffirmed commitment to its $422 million annual revenue target, the firm is positioning 2026 as a pivotal turnaround year. Investors are closely watching the upcoming March 3, 2026, earnings call for updates on the integration of its Purvala biotech assets.

Looking ahead, the company is prioritizing international expansion—particularly in the Asia-Pacific region—and the deployment of AI-driven tools to personalize the consumer regimen. By leveraging its data-rich DTC platform and an "agentic" approach to social media marketing, Olaplex aims to recapture the momentum of its IPO years. With a lean employee base of just over 230 and a disciplined focus on maintaining Adjusted EBITDA margins in the high 20% range, the firm is focused on balancing aggressive brand-building with the operational efficiency required to navigate a volatile consumer discretionary environment.